CD8+ T Cell Detection for Tuberculosis Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for tuberculosis, particularly in children and latent infections, are inadequate due to low sensitivity and specificity, and existing vaccines like BCG are controversial and ineffective in distinguishing between vaccinated and infected individuals.
Innovation Solution
The method involves isolating and detecting CD8+ T cells that specifically respond to Mycobacterium tuberculosis polypeptides such as ESAT-6 and CFP-10 by measuring cytokine expression, particularly interferon-γ, and administering these polypeptides to detect latent or active tuberculosis infections.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional diagnostic methods (skin test, sputum smear) are used for tuberculosis detection, then the procedures are simple and widely available, but the sensitivity and specificity are low, especially in children and latent infections
Solution Approach 1:
The patent replaces traditional mechanical/diagnostic methods (skin testing, sputum smears) with a molecular biology-based detection system that identifies specific T cell responses to mycobacterial antigens. This substitution enables more accurate detection of latent and active tuberculosis infections, particularly in children, by detecting cellular immune responses rather than relying on sputum production or skin reaction tests.
Solution Approach 2:
The patent changes the detection parameter from physical/chemical markers (acid-fast bacilli in sputum, skin induration) to immunological markers (T cell cytokine production). This parameter change allows detection of tuberculosis infection at the cellular immune response level, significantly improving sensitivity and specificity for latent and pediatric cases.
2Reliability
If BCG vaccine is used for tuberculosis prevention, then protective immunity is induced, but the vaccine cannot distinguish between vaccinated and infected individuals, and efficacy is controversial
Solution Approach 1:
The patent segments the mycobacterial antigens into specific peptides (ESAT-6, CFP-10) that are present in active tuberculosis but not in BCG vaccine or latent infections. This segmentation allows the detection system to distinguish between vaccinated, latently infected, and actively infected individuals by targeting antigen-specific T cell responses to these unique peptides.
Solution Approach 2:
The patent uses antigen-specific T cells as an intermediary to detect tuberculosis infection. These T cells serve as a mediator that can distinguish between different states of mycobacterial exposure (vaccination vs. infection) by recognizing specific antigen peptides, thereby providing the information that was previously lost in traditional diagnostic approaches.
3Loss of time
If early detection of tuberculosis is implemented, then disease progression can be prevented, but current methods fail to detect latent infections and pediatric cases accurately
Solution Approach 1:
The patent employs the host's own immune system (T cells) as the detection mechanism. By stimulating T cells with mycobacterial antigens and detecting their cytokine production, the system uses the body's natural immune response to detect infection, eliminating the need for external markers or complex imaging techniques and enabling early detection of latent and pediatric cases.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for accurate detection of tuberculosis in children and latent infections by identifying specific T cell responses, improving diagnostic accuracy and distinguishing between vaccinated and infected individuals.
Implementation Method 1
detecting the presence of reactive CD8+ T cells in a biological sample from a subject when the sample is incubated with an Mtb polypeptide or a fragment or derivative of the Mtb polypeptide that binds to an MHC molecule
Implementation Method 2
measuring cytokine expression, particularly interferon-γ
Data Source
AI summary
Methods for detecting an infection with Mycobacterium tuberculosis (Mtb) in a subject are disclosed, wherein the subject is a child, a subject with a latent Mycobacterium tuberculosis infection. Method are also disclose for detecting an extra-pulmonary Mycobacterium tuberculosis infection in a subject. The methods include detecting the presence of CD8+ T cells that specifically recognize an Mtb polypeptide. The methods include in vitro assays for detecting the presence of CD8+ T cells in a biological sample.